HIGHCAPE PARTNERS
HighCape partners (“HighCape”) is a growth equity firm that invests in companies that are commercializing high-margin life sciences products. They transform Their portfolio companies into scalable commercial entities (SCEs), allowing them to become sustainable businesses with multiple exit alternatives.
HIGHCAPE PARTNERS
Social Links:
Industry:
Financial Services
Founded:
2013-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-11-03 | Wellinks | HighCape Partners investment in Series C - Wellinks | 25 M USD |
| 2021-03-10 | Cybrexa Therapeutics | HighCape Partners investment in Series B - Cybrexa Therapeutics | 25 M USD |
| 2020-12-15 | Alphina Therapeutics | HighCape Partners investment in Venture Round - Alphina Therapeutics | N/A |
| 2019-09-27 | Flyp Nebulizer | HighCape Partners investment in Series B - Flyp Nebulizer | 4 M USD |
| 2019-09-26 | Wellinks | HighCape Partners investment in Series B - Wellinks | 14 M USD |
| 2019-06-21 | Cybrexa Therapeutics | HighCape Partners investment in Series B - Cybrexa Therapeutics | 13.4 M USD |
| 2018-06-19 | Zipline Medical | HighCape Partners investment in Series F - Zipline Medical | 9 M USD |
| 2017-09-12 | Cheetah Medical | HighCape Partners investment in Series C - Cheetah Medical | 11.76 M USD |
| 2017-06-16 | Cybrexa Therapeutics | HighCape Partners investment in Series B - Cybrexa Therapeutics | 6 M USD |
| 2017-06-14 | Aziyo Biologics | HighCape Partners investment in Venture Round - Aziyo Biologics | 12 M USD |